Military battlefield wound care

The inclusion of cetrimide in the Medi-Solfen^® formulation may provide clinical benefits in provision of antibacterial activity in the wound over and above washing with saline or water prior to wound closure.

Presently, with the level of small arms and fragment protection that is issued to UK Armed Forces, the survival rate following combat trauma is approximately 98%; however, there has been an increase in the number of extremities, groin, and facial wounds, as these are areas that are not as well shielded by individual combat armour.

The US Department of Defense (USDOD) is seeking a topical anaesthetic wound care agent to be used for frontline pain management of acute traumatic wounds. In 2020 they commissioned an independent scientific review by US Army Medical Research & Development Command (USAMRDC) to determine merits of undertaking a detailed project to study the utilisation of Medi-Solfen^® for treating combat wounds.

Peer Review Overall Evaluation of Medi-Solfen’s^® merits rated the product as 1.6 (on a scale 1.0 highest to 5.0 lowest).

Medi-Solfen^® has the potential to reduce the use of morphine in the battlefield environment and be very effective at reducing pain.

Lieutenant Colonel Steve Jeffery,
Consultant burns and plastic surgeon

98%Survival rate following combat trauma

The survival rate following combat trauma is approximately 98% in the UK Armed Forces however, there has been an increase in the number wounds in areas that are not as well shielded by individual combat armour.

Wound care